Corsee Sanders, Ph.D. Email and Phone Number
Corsee Sanders, Ph.D. work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Corsee Sanders, Ph.D. personal email
- Valid
Corsee Sanders, Ph.D. phone numbers
I am so fortunate to have had a career that has allowed me to contribute in developing treatments that improve patient's lives, at the senior executive level as well as at the Biometrics, Biostatistics and Clinical Operations functional levels, across Oncology, Autoimmune, Ophthalmology and Neurological diseases.- Board Experience. Board director at publicly traded and privately held companies and trustee of a non-profit research organizations engaged in biopharmaceutical research. Provides strategic insight and guidance in the quantitative science, operating, commercial, and regulatory requirements for successful drug development. Currently serving on four boards. - Clinical Trials. Designs and implements clinical trials and evaluates and interprets the results for drug development and management decision-making. Ensures that trials are structured to be cost-effective and with minimum burden to patients and physicians. Had led hundreds of clinical trial implementations in 70+ countries and regulatory jurisdictions.- Biopharmaceutical Development. Track record in providing insight and contributing to the development of a wide range of therapies such as Claritin, Rituxan, Herceptin, TNKase, Cathflo, Xolair, Avastin, Tarceva, Lucentis, Zelboraf, Perjeta, Erivedge, Gazyva, Kadcyla, Alecensa, Cotellic, Venclexta, Tecentriq, Ocrevus, Hemlibra, and JCAR017 (a CAR T cell therapy for NHL). - Quantitative Sciences/Analytics. Applies data sciences and biostatistics expertise to design productive clinical trials that utilize standardized as well as innovative methodologies. Extensive career background evaluating and interpreting analytics in senior corporate roles at major biopharmaceutical companies. Ph.D. in Statistics from the Wharton School. - Operations/Executive Leadership. Proven capability to design, build, and lead large organizations with thousands of clinical trial professionals working across multiple geographies. Develops effective organizational structures, processes, and governance. Member of corporate executive and portfolio management committees.
-
Board MemberUltragenyx Pharmaceutical Inc.Seattle, Wa, Us
-
Board MemberUltragenyx Pharmaceutical Inc. Jun 2021 - PresentNovato, California, Us -
Advisory Committee MemberGeorge Schultz Innovation Fund Of The University Of Chicago Oct 2020 - Present
-
Board MemberBeigene Aug 2020 - PresentCambridge, Ma, Us -
Board MemberLegend Biotech May 2020 - PresentSomerset, New Jersey, Us -
Board MemberAltrubio Inc. Mar 2020 - PresentSan Francisco, California, Us -
Member Of The Board Of DirectorsMolecular Templates Dec 2019 - PresentAustin, Texas, Us -
Co-Chair Of The Board Of Advisors | Chair Of The Science And Technology Advisory CommitteeFred Hutch Jun 2019 - PresentSeattle, Wa, UsThe mission of Fred Hutch is the elimination of cancer and related diseases as causes of human suffering and death. The Hutch conducts research of the highest standards to improve prevention and treatment of cancer and related diseases. -
Member Of Life Science CouncilSpringboard Enterprises Nov 2018 - PresentMclean, Virginia, Us -
Interim Strategic AdviserBristol-Myers Squibb Nov 2019 - Feb 2020Lawrence Township, Nj, Us -
Evp Juno Therapeutics And Advisor To The Celgene Office Of The CmoCelgene Mar 2018 - Nov 2019Summit, New Jersey, UsServed as strategic advisor to the CMO. Ensured the effective integration of Juno’s CAR T Development Organization into the Celgene Organization and advised the CMO and his team on leadership and processes development processes.Focus: CAR T Projects and Clinical Development Operations: Biostatistics, QC, Data Management, Clinical Operations, Operational Excellence -
Executive Vice President, Head Of Strategic Development Operations And Quantitative SciencesJuno Therapeutics, Inc. Jan 2017 - Apr 2018Seattle, Wa, UsReporting to the CEO, member of the EC, responsible for the planning, management, execution, analysis, and reporting of Juno’s clinical trials.Scope: portfolio leaders and management; clinical and data operations; medical and CMC writing; clinical, manufacturing and research statistics and data sciences; CAR T patient operations;Served on the Executive Committee, the leadership team driving the strategy and delivery of the company’s mission. Oversaw the governance, management, execution, analysis, and reporting of the company’s CAR T programs, including Corporate Project Leadership and Management, CAR T Apheresis and Clinical Operations, Biometrics, and Biosample Operations. • Instituted the data sharing governance and integration across translational research, clinical research, and product manufacturing that is unique to CAR T drug development.• Built the Quantitative Sciences and Strategic Operations organization targeted to CAR T development. -
Svp, Genentech | Global Head Of Roche Clinical Operations And External CollaborationGenentech Apr 2012 - Jan 2017South San Francisco, California, UsLed the organization responsible for the operational strategy, planning, and execution of global and local clinical trials in 70+ countries, including exploring and embedding innovative and technology-driven approaches to transform clinical trial execution. Reported to the Roche Chief Medical Officer and managed six Vice President and Senior Director direct reports. Overall team numbered 2,500 professionals across five strategic and 20 local country sites. Managed industry collaborations, such as the Clinical Trials Transformation Initiative (CTTI) and TransCelerate Biopharma. Member of the Roche Late Stage Portfolio Committee and Chair of the Roche Data Review Board.• Established sourcing model and performance analytics within clinical operations.• Executed the Genentech and Roche clinical plans for 200+ programs.• Developed industry efficiency solutions through TransCelerate Biopharma, as Board Member and Vice Chair (See Board of Director Experience above).Co-Chair, Roche-Chugai Joint Portfolio Management Committee (2011-2017)Served as Member and Co-Chair of the Committee and provided oversight of the pre-licensing process and alignment of the development and commercial strategies of cross-licensed assets• Ensured value of the Roche-Chugai Alliance through operational and governance improvements• Oversaw the cross-licensing of products, including Hemlibra. -
Svp Genentech, Global Head Roche Biometrics And InnovationsGenentech May 2009 - Apr 2012South San Francisco, California, UsAdvanced from Vice President to Senior Vice President with responsibility for Clinical and Nonclinical Biostatistics, Epidemiology and Outcomes Research, Clinical Data Management, Statistical Programming, Strategic Planning, Operations, Communication, and Collaboration. Reported to the Chief Medical Officer and supervised uo to eight Director and Vice President-level direct reports, with overall team numbering 1,100 professionals working in six countries. Member of the Late Stage Portfolio Committee.• Led and oversaw the analytical strategy and data delivery of Zelboraf, Perjeta, Erivedge, Gazyva, Kadcyla, Alecensa, Cotellic, Venclexta, Tecentriq, Ocrevus. • Launched the TransCelerate Biopharma collaboration as member of the board
-
Vp Data Group - DevelopmentGenentech Jul 1994 - Apr 2009South San Francisco, California, Us
-
Transcelerate Board Of Directors MemberTranscelerate Biopharma, Inc Jul 2012 - Nov 2016Conshohocken, Pennsylvania, UsThe Board of Directors is responsible for managing the business and affairs of TransCelerate BioPharma Inc. As a Board member, I provide strategic guidance, on behalf of Roche Pharmaceuticsls, to TransCelerate for effective oversight of the management of the organization.
Corsee Sanders, Ph.D. Skills
Corsee Sanders, Ph.D. Education Details
-
University Of PennsylvaniaMathematical Statistics And Probability -
The Wharton SchoolStatistics
-
University Of The PhilippinesStatistics
Frequently Asked Questions about Corsee Sanders, Ph.D.
What company does Corsee Sanders, Ph.D. work for?
Corsee Sanders, Ph.D. works for Ultragenyx Pharmaceutical Inc.
What is Corsee Sanders, Ph.D.'s role at the current company?
Corsee Sanders, Ph.D.'s current role is Board Member.
What is Corsee Sanders, Ph.D.'s email address?
Corsee Sanders, Ph.D.'s email address is co****@****ics.com
What is Corsee Sanders, Ph.D.'s direct phone number?
Corsee Sanders, Ph.D.'s direct phone number is +165028*****
What schools did Corsee Sanders, Ph.D. attend?
Corsee Sanders, Ph.D. attended University Of Pennsylvania, The Wharton School, University Of The Philippines.
What skills is Corsee Sanders, Ph.D. known for?
Corsee Sanders, Ph.D. has skills like Clinical Trials, Pharmaceutical Industry, Drug Development, Clinical Development, Biotechnology, Oncology, Biopharmaceuticals, Life Sciences, Regulatory Submissions, Management, Fda, Ctms.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial